Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease Trial Phase 2 Completed May 15, 2019
Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease Trial Phase 2 Completed May 13, 2019
The Effects of Dual Task Training in Individuals With Parkinson's Disease Trial N/A Completed May 2, 2019
Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease. Trial Phase 3 Terminated May 2, 2019
Lipoprotein Metabolism and Bacterial Lipopolysaccharide in Parkinson's Disease Trial N/A Completed May 2, 2019
Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders Trial N/A Completed April 25, 2019
SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) Trial Phase 2 Completed April 18, 2019
Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism Trial N/A Completed April 17, 2019
The Effect of Resistance Training in Parkinson Disease: A Pilot Study Trial N/A Completed April 17, 2019
Contribution of Virtual Reality and Modelling in Falling Risk Assessment in Elderly and Parkinson's Disease Patients Trial N/A Unknown April 15, 2019
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease Trial Phase 2 Terminated April 15, 2019